Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) in chronic hypoxia- and antigen-mediated pulmonary vascular remodeling

BackgroundBoth chronic hypoxia and allergic inflammation induce vascular remodeling in the lung, but only chronic hypoxia appears to cause PH. We investigate the nature of the vascular remodeling and the expression and role of hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) in explaining this differential response.MethodsWe induced pulmonary vascular remodeling through either chronic hypoxia or antigen sensitization and challenge. Mice were evaluated for markers of PH and pulmonary vascular remodeling throughout the lung vascular bed as well as HIMF expression and genomic analysis of whole lung.ResultsChronic hypoxia increased both mean pulmonary artery pressure (mPAP) and right ventricular (RV) hypertrophy; these changes were associated with increased muscularization and thickening of small pulmonary vessels throughout the lung vascular bed. Allergic inflammation, by contrast, had minimal effect on mPAP and produced no RV hypertrophy. Only peribronchial vessels were significantly thickened, and vessels within the lung periphery did not become muscularized. Genomic analysis revealed that HIMF was the most consistently upregulated gene in the lungs following both chronic hypoxia and antigen challenge. HIMF was upregulated in the airway epithelial and inflammatory cells in both models, but only chronic hypoxia induced HIMF upregulation in vascular tissue.ConclusionsThe results show that pulmonary vascular remodeling in mice induced by chronic hypoxia or antigen challenge is associated with marked increases in HIMF expression. The lack of HIMF expression in the vasculature of the lung and no vascular remodeling in the peripheral resistance vessels of the lung is likely to account for the failure to develop PH in the allergic inflammation model.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  Yan Sun,et al.  Found in Inflammatory Zone 1 Induces Angiogenesis in Murine Models of Asthma , 2008, Lung.

[3]  S. Dhanasekaran,et al.  FIZZ1 stimulation of myofibroblast differentiation. , 2004, The American journal of pathology.

[4]  N. Morrell,et al.  Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. , 2002, Progress in cardiovascular diseases.

[5]  G. Butrous,et al.  Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis. , 2010, American journal of respiratory and critical care medicine.

[6]  Jinshui Fan,et al.  Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients , 2011, PloS one.

[7]  Liduan Zheng,et al.  Hypoxia-Induced Mitogenic Factor Promotes Vascular Adhesion Molecule-1 Expression via the PI-3K/Akt–NF-κB Signaling Pathway , 2006 .

[8]  R. Johns Th2 inflammation, hypoxia-induced mitogenic factor/FIZZ1, and pulmonary hypertension and vascular remodeling in schistosomiasis. , 2010, American journal of respiratory and critical care medicine.

[9]  L. Piccio,et al.  Cutting Edge: TREM-2 Attenuates Macrophage Activation1 , 2006, The Journal of Immunology.

[10]  S. Phan,et al.  Antiapoptotic effect of found in inflammatory zone (FIZZ)1 on mouse lung fibroblasts , 2007, The Journal of pathology.

[11]  C. Cheadle,et al.  Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELMα) Increases Lung Inflammation and Activates Pulmonary Microvascular Endothelial Cells via an IL-4–Dependent Mechanism , 2010, The Journal of Immunology.

[12]  I. Purvis,et al.  Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis. , 2011, American journal of respiratory and critical care medicine.

[13]  M. Humbert,et al.  The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension , 2013, Clinical Reviews in Allergy & Immunology.

[14]  T. L. Le Cras,et al.  Chronic Allergic Inflammation Causes Vascular Remodeling and Pulmonary Hypertension in Bmpr2 Hypomorph and Wild-Type Mice , 2012, PloS one.

[15]  Liduan Zheng,et al.  Hypoxia-induced mitogenic factor modulates surfactant protein B and C expression in mouse lung. , 2006, American journal of respiratory cell and molecular biology.

[16]  R. Johns,et al.  Bruton's tyrosine kinase (BTK) is a binding partner for hypoxia induced mitogenic factor (HIMF/FIZZ1) and mediates myeloid cell chemotaxis , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  J. Erjefält,et al.  Allergen exposure of mouse airways evokes remodeling of both bronchi and large pulmonary vessels. , 2005, American journal of respiratory and critical care medicine.

[18]  Chris Cheadle,et al.  Application of z-score transformation to Affymetrix data. , 2003, Applied bioinformatics.

[19]  M. Rothenberg,et al.  Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis. , 2008, The Journal of allergy and clinical immunology.

[20]  R. Johns,et al.  Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension. , 2009, American journal of respiratory cell and molecular biology.

[21]  R. Johns,et al.  Hypoxia-induced mitogenic factor has antiapoptotic action and is upregulated in the developing lung: coexpression with hypoxia-inducible factor-2alpha. , 2004, American journal of respiratory cell and molecular biology.

[22]  Chuanshu Huang,et al.  VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-κB signaling pathway , 2006, Respiratory research.

[23]  N. Lee,et al.  Diagnosis and assessment of pulmonary arterial hypertension , 2010 .

[24]  Chuanshu Huang,et al.  Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells. , 2006, Experimental cell research.

[25]  C. Munaut,et al.  Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension , 2005, European Respiratory Journal.

[26]  C. Ricachinevsky,et al.  Treatment of pulmonary arterial hypertension. , 2006, Jornal de pediatria.

[27]  B. Camoretti-Mercado,et al.  FIZZ1 Plays a Crucial Role in Early Stage Airway Remodeling of OVA-Induced Asthma , 2008, The Journal of asthma : official journal of the Association for the Care of Asthma.

[28]  A. Anwar,et al.  Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[29]  R. Johns,et al.  Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELMα) Recruits Bone Marrow-Derived Cells to the Murine Pulmonary Vasculature , 2010, PloS one.

[30]  V. Kurup,et al.  Pulmonary arterial remodeling induced by a Th2 immune response , 2008, The Journal of experimental medicine.

[31]  M. Rabinovitch,et al.  Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. , 1996, Circulation research.

[32]  T. Welte,et al.  Pivotal role of cathepsin K in lung fibrosis. , 2004, The American journal of pathology.

[33]  R. Mecham,et al.  Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. , 1987, Science.

[34]  R. Mecham,et al.  Vascular remodeling in neonatal pulmonary hypertension. Role of the smooth muscle cell. , 1988, Chest.

[35]  M. Frid,et al.  Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[36]  A. Stütz,et al.  The Th2 Cell Cytokines IL-4 and IL-13 Regulate Found in Inflammatory Zone 1/Resistin-Like Molecule α Gene Expression by a STAT6 and CCAAT/Enhancer-Binding Protein-Dependent Mechanism , 2003, The Journal of Immunology.

[37]  T. Wibmer,et al.  Circulating biomarkers of tissue remodelling in pulmonary hypertension , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[38]  R. Johns,et al.  FIZZ1/RELM&agr;, a Novel Hypoxia-Induced Mitogenic Factor in Lung With Vasoconstrictive and Angiogenic Properties , 2003, Circulation research.

[39]  R. Speich,et al.  Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[40]  R. Johns,et al.  Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMalpha) induces the vascular and hemodynamic changes of pulmonary hypertension. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[41]  G. Butrous,et al.  Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling. , 2010, The American journal of pathology.

[42]  S. Swain,et al.  Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia. , 2007, The American journal of pathology.

[43]  R. Johns,et al.  Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[44]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Jones,et al.  Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. , 1997, The American journal of pathology.

[46]  Joseph Loscalzo,et al.  Pathogenic mechanisms of pulmonary arterial hypertension. , 2008, Journal of molecular and cellular cardiology.

[47]  R. Johns,et al.  Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat. , 1996, Hypertension.

[48]  R. Baier,et al.  CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia , 2004, Pediatric pulmonology.

[49]  M. Humbert,et al.  Inflammation in pulmonary arterial hypertension , 2003, European Respiratory Journal.

[50]  R. Johns,et al.  Regression of chronic hypoxic pulmonary hypertension by simvastatin. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[51]  Chris Cheadle,et al.  GSMA: Gene Set Matrix Analysis, An Automated Method for Rapid Hypothesis Testing of Gene Expression Data , 2007, Bioinformatics and biology insights.

[52]  J. Erjefält,et al.  Remodeling of extra-bronchial lung vasculature following allergic airway inflammation , 2008, Respiratory research.

[53]  Seon-Young Kim,et al.  PAGE: Parametric Analysis of Gene Set Enrichment , 2005, BMC Bioinform..

[54]  W. Seeger,et al.  Human RELMβ is a mitogenic factor in lung cells and induced in hypoxia , 2006, FEBS letters.

[55]  F. Peale,et al.  FIZZ1, a novel cysteine‐rich secreted protein associated with pulmonary inflammation, defines a new gene family , 2000, The EMBO journal.

[56]  R. Johns,et al.  eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[57]  Biao Hu,et al.  Regulation of Found in Inflammatory Zone 1 Expression in Bleomycin-Induced Lung Fibrosis: Role of IL-4/IL-13 and Mediation via STAT-61 , 2004, The Journal of Immunology.

[58]  R. Johns,et al.  IL-4 Is Proangiogenic in the Lung under Hypoxic Conditions1 , 2009, The Journal of Immunology.

[59]  H. Boushey,et al.  The Epithelial Anion Transporter Pendrin Is Induced by Allergy and Rhinovirus Infection, Regulates Airway Surface Liquid, and Increases Airway Reactivity and Inflammation in an Asthma Model1 , 2008, The Journal of Immunology.

[60]  Chuanshu Huang,et al.  Participation of the PI-3K/Akt-NF-κB signaling pathways in hypoxia-induced mitogenic factor-stimulated Flk-1 expression in endothelial cells , 2006, Respiratory research.

[61]  D. Lison,et al.  Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-β , 2005, Respiratory research.

[62]  R. Tuder,et al.  Pathology of pulmonary hypertension. , 2007, Clinics in chest medicine.

[63]  C. Cheadle,et al.  Resistin-like molecule α stimulates proliferation of mesenchymal stem cells while maintaining their multipotency. , 2013, Stem cells and development.

[64]  V. Laubach,et al.  Upregulation of hypoxia-induced mitogenic factor in compensatory lung growth after pneumonectomy. , 2005, American journal of respiratory cell and molecular biology.

[65]  G. Butrous,et al.  Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. , 2010, Chest.

[66]  Robin Shandas,et al.  Changes in the structure-function relationship of elastin and its impact on the proximal pulmonary arterial mechanics of hypertensive calves. , 2008, American journal of physiology. Heart and circulatory physiology.

[67]  E. Green,et al.  Identification of Pendrin as a Common Mediator for Mucus Production in Bronchial Asthma and Chronic Obstructive Pulmonary Disease1 , 2008, The Journal of Immunology.

[68]  M. Rojas,et al.  Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. , 2006, American journal of respiratory cell and molecular biology.

[69]  M. d’Ortho,et al.  Inhibition of Matrix Metalloproteinases by Lung TIMP-1 Gene Transfer or Doxycycline Aggravates Pulmonary Hypertension in Rats , 2000, Circulation research.

[70]  D. McKean,et al.  Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[71]  R. Johns,et al.  Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. , 2003, American journal of physiology. Heart and circulatory physiology.